FDA Clearance Tracker · P160042-S010
Revanesse® Lips+
Last checked: Nov 20, 2026Latest source record: Sep 21, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Sep 21, 2020
Approved
Time to decision
357 days
Received Sep 30, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P160042-S010
- Device name
- Revanesse® Lips+
- Applicant location
- Aurora
- Received
- Sep 30, 2019
- Decided
- Sep 21, 2020
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P160042
Device type
- Device type
- Implant, dermal, for aesthetic use (LMH)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Revanesse® Lips+. The device is indicated for submucosal implantation for lip augmentation in patients 22 years of age or older.
Source documents
Other decisions for Prollenium Medical Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P160042 · Decided Aug 4, 2017 · 316 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.